Relapsing-remitting multiple sclerosis and Mycobacterium avium complex infection

Summary:

Mycobacterium avium complex infection is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 60+ old.

The study analyzes which people have Mycobacterium avium complex infection with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 13 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Mycobacterium avium complex infection?

Mycobacterium avium complex infection is found to be associated with 319 drugs and 409 conditions by eHealthMe. Check the latest studies of Mycobacterium avium complex infection.

On Jul, 26, 2026

13 people who have Relapsing-Remitting Multiple Sclerosis and Mycobacterium Avium Complex Infection are studied.

Would you have Mycobacterium avium complex infection when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Mycobacterium Avium Complex Infection *:

female: 75 %
male: 25 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Mycobacterium Avium Complex Infection *:

Common co-existing conditions for these people *:

Muscle Spasms (muscle contraction): 3 people, 23.08%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 15.38%
Hypersensitivity: 2 people, 15.38%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 15.38%
Cardiac Discomfort: 2 people, 15.38%
Neuralgia (pain in one or more nerves): 1 person, 7.69%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 7.69%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 5 people, 38.46%
Cd4 Lymphocytes Decreased: 4 people, 30.77%
Productive Cough: 4 people, 30.77%
Dyspnea (difficult or laboured breathing): 4 people, 30.77%
Back Pain: 3 people, 23.08%
Staphylococcus Test Positive: 3 people, 23.08%
Pneumonia: 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Dyspnea Exertional: 3 people, 23.08%
Urine Leukocyte Esterase Positive: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Mycobacterium avium complex infection?

- Check whether Mycobacterium avium complex infection is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Relapsing-remitting multiple sclerosis (76,275 reports)
Mycobacterium avium complex infection (6,850 reports)

All the drugs that are associated with Mycobacterium avium complex infection:

Mycobacterium avium complex infection (319 drugs)

All the conditions that are associated with Mycobacterium avium complex infection:

Mycobacterium avium complex infection (409 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Mycobacterium avium complex infection and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.